| Literature DB >> 32528686 |
A Pormohammad1,2, H Goudarzi1, G Eslami1, F Falah1, F Taheri1, N Ghadiri1, E Faghihloo1.
Abstract
From the early 18th century that "meningitis" outbreak was firstly recorded in Geneva, it is one of the alarming health problems worldwide. Different infectious risk factors may contribute to the progression of meningitis. Herpes simplex virus (HSV) and Varicella-zoster virus (VZV) are just some noticeable risk factors among many involved in the progression of this disease. In this study, 415 meningitis suspected patients were recruited with some symptoms, such as fever, headache, nausea or vomiting, seizure, rash, dizziness from four different hospitals of Iran and molecular examinations of samples were performed by using specific primers of HSV½ and VZV via real-time PCR. Out of 415 included patient 41 (9.8 %) were VZV and six (1.4 %) cases were HSV ½ positive. Fever was the most frequent symptom by 315 (76 %) of patients with median temperature of 38 °C in all included patients. The median WBS counts of CSF in VZV positive, HSV½ positive, and all included cases were 1567 × 106 /L, 1257 × 106 /L, and 766 × 106 /L (range 0-21200), respectively. In conclusion, as the rate of VZV infection was high among children patients and it was associated with the absence of vaccination program for chickenpox in Iran, we suggested that VZV is one of the plausible hallmarks in meningitis.Entities:
Keywords: Cerebrospinal fluid; Herpes simplex virus; Meningitis; Real-time PCR; Varicella zoster virus
Year: 2020 PMID: 32528686 PMCID: PMC7276451 DOI: 10.1016/j.nmni.2020.100688
Source DB: PubMed Journal: New Microbes New Infect ISSN: 2052-2975
Sequences of primers used in the study
| Gene | Primer sequence | Ref. |
|---|---|---|
| HSV-1, HSV-2 ( | CCACCGTCAGCACCTTCAT | [ |
| HSV-1, HSV-2 ( | CGCTGGACCTCCGTGTAGTC | [ |
| VZV ( | GCGCTCTAACGTTCGAGAAAGT | [ |
| VZV ( | CGCATAGCCAACCAGTCTTTT | [ |
| IC (β-globin) F | GAAGAGCCAAGGACAGGTAC | [ |
| IC (β-globin) R | CAACTTCATCCACGTTCACC | [ |
HSV, herpes simplex virus; IC, internal control; VZV, varicella zoster virus.
Demographic data and laboratory findings in varicella zoster virus-infected patients and total of children with suspected meningitis
| Variables mean (range) or | VZV positive ( | VZV negative ( | Total ( |
|---|---|---|---|
| Demographics | |||
| Age (months) | 21 (0.6–90) | 32 (0.1–168) | 33 (0.10–180) |
| Male/Female | 26/15 | 198/176 | 233/182 |
| Fever | 38 (37–40) | 38.4 (36–40) | 38 (36–40) |
| Headache | 3 (0.7%) | 62 (15 %) | 68 (16.2%) |
| Nausea or vomiting | 25 (6%) | 128 (39.6%) | 178 (43%) |
| Seizure | 10 (2.5%) | 77 (18.6%) | 90 (21.6%) |
| Rash | 1 (0.3%) | 26 (6.2%) | 24 (5.7%) |
| Dizziness | 5 (1.5%) | 20 (4.9%) | 32 (7.7%) |
| Laboratory | |||
| CSF WBC count | 1567 (0–21 200) | 677 (0–21 200) | 766 (0–21 200) |
| CSF RBC count | 5.4 (0–85) | 1.6 (0–85) | 1.4 (0–85) |
| CSF protein | 107.5 (5–670) | 100.5 (5–878) | 87 (5–878) |
| CSF glucose | 48.8 (10–80) | 54 (3–107) | 54 (3–116) |
| Serum CRP | 44 (1–149) | 39 (1–149) | 36 (1–149) |
CRP, C-reactive protein; CSF, cerebrospinal fluid; RBC, red blood cell; VZV, varicella zoster virus; WBC, white blood cell.
The reference ranges of laboratory tests for WBC, RBC, protein, glucose in CSF are 0–10/mm3, 0–10/mm3, 20–40 mg/dL, 45–80 mg/dL, respectively.